Altered VEGF-stimulated Ca2+ signaling in part underlies pregnancy-adapted eNOS activity in UAEC

Journal of Endocrinology

Volumn 223, Issue 1, 2014, Pages 1-11

  Boeldt, Derek S ^a   Grummer, Mary A ^a   Magness, Ronald R ^a,b   Bird, Ian M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Adaptation; Endothelium; Pregnancy; VEGF

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 AMINOETHOXYDIPHENYLBORANE; ARGININE; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FURA 2 ACETOXYMETHYL ESTER; INOSITOL 1,4,5 TRISPHOSPHATE; NITRIC OXIDE; PHOSPHOLIPASE C; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN E; VASCULOTROPIN RECEPTOR 2; 1-(6-((3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL)-1H-PYRROLE-2,5-DIONE; 2 PYRROLIDONE DERIVATIVE; 2-AMINOETHOXYDIPHENYLBORANE; BORON DERIVATIVE; CALCIUM; ESTRANE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; VASCULOTROPIN A;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; FEMALE; NONHUMAN; PREGNANCY; UTERINE ARTERY ENDOTHELIAL CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; SHEEP; SIGNAL TRANSDUCTION; UTERINE ARTERY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BORON COMPOUNDS; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ESTRENES; FEMALE; INOSITOL 1,4,5-TRISPHOSPHATE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHODIESTERASE INHIBITORS; PREGNANCY; PYRROLIDINONES; SHEEP; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES; UTERINE ARTERY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84907875312     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-14-0252     Document Type: Article

References (24)

1. Bird IM, Sullivan JA, Di T, Cale JM, Zhang L, Zheng J&Magness RR 2000 Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells. Endocrinology 141 1107-1117. (doi:10.1210/endo.141.3.7367)
2. Bird IM, Zhang L&Magness RR 2003 Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 284 R245-R258. (doi:10.1152/ajpregu.00108.2002)
3. Cale JM&Bird IM 2006 Dissociation of endothelial nitric oxide synthase phosphorylation and activity in uterine artery endothelial cells. American Journal of Physiology. Heart and Circulatory Physiology 290 H1433-H1445. (doi:10.1152/ajpheart.00942.2005)
4. 2. Endocrinology 142 3014-3026. (doi:10.1210/endo.142.7.8278)
5. Ge R, Tai Y, Sun Y, Zhou K, Yang S, Cheng T, Zou Q, Shen F&Wang Y 2009 Critical role of TRPC6 channels in VEGF-mediated angiogenesis. Cancer Letters 283 43-51. (doi:10.1016/j.canlet.2009.03.023)
6. Gifford SM, Cale JM, Tsoi S, Magness RR&Bird IM 2003 Pregnancy-specific changes in uterine artery endothelial cell signaling in vivo are both programmed and retained in primary culture. Endocrinology 144 3639-3650. (doi:10.1210/en.2002-0006)
7. 2+ entry rather than altered receptor coupling. Journal of Endocrinology 190 373-384. (doi:10.1677/joe.1.06635)
8. 2+ channel function in uterine artery endothelial cells is associated with enhanced agonist-specific transient receptor potential channel 3-inositol 1,4,5-trisphosphate receptor 2 interaction. Journal of Endocrinology 190 385-395. (doi:10.1677/joe.1.06773)
9. Grummer MA, Sullivan JA, Magness RR&Bird IM 2009 Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells. Biochemical Journal 417 501-511. (doi:10.1042/BJ20081013)
10. 2+ signaling underlies suppressed endothelial nitric oxide production in preeclamptic pregnancies: implications for new therapy. American Journal of Physiology. Heart and Circulatory Physiology 305 H969-H979. (doi:10.1152/ajpheart.00250.2013)
11. Magness RR 1998 Maternal cardiovascular and other physiologic responses to the endocrinology of pregnancy. In Endocrinology of Pregnancy, Ch 18, pp 507-539. Ed F Bazer. Totowa, NJ, USA: Humana Press. (doi:10.1007/978-1-4612-1804-3_18)
12. Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Buttner M, Rziha HJ&Dehio C 1999 A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO Journal 18 363-374. (doi:10.1093/emboj/18.2.363)
13. Ogawa S, Oku A, Sawano A, Yamaguchi S, Yazaki Y&Shibuya M 1998 A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. Journal of Biological Chemistry 273 31273-31282. (doi:10.1074/jbc.273.47.31273)
14. Park JE, Chen HH, Winer J, Houck KA&Ferrara N 1994 Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. Journal of Biological Chemistry 269 25646-25654.
15. Rameh LE, Rhee SG, Spokes K, Kazlauskas A, Cantley LC&Cantley LG 1998 Phosphoinositide 3-kinase regulates phospholipase Cγ-mediated calcium signaling. Journal of Biological Chemistry 273 23750-23757. (doi:10.1074/jbc.273.37.23750)
16. Sladek SM, Magness RR&Conrad KP 1997 Nitric oxide and pregnancy. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 272 R441-R463.
17. 2+, U0126, and Wortmannin but not LY294002-evidence that pregnancy adaptation of eNOS activation occurs at multiple levels of cell signaling. Endocrinology 147 2442-2457. (doi:10.1210/en.2005-0399)
18. 2+) values for calmodulin binding and enzyme activation. Journal of Biological Chemistry 284 11892-11899. (doi:10.1074/jbc.M806205200)
19. Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB&Joyner-Grantham J 2009 Vasodilator factors in the systemic and local adaptations to pregnancy. Reproductive Biology and Endocrinology 7 79. (doi:10.1186/1477-7827-7-79)
20. Walsh SW 2004 Eicosanoids in preeclampsia. Prostaglandins, Leukotriens, and Essential Fatty Acids 70 223-232. (doi:10.1016/j.plefa.2003.04.010)
21. 2+ bursts and endothelial nitric oxide synthase activation in ovine uterine artery endothelial cells through increased connexin 43 function. Biology of Reproduction 82 66-75. (doi:10.1095/biolreprod.109.078253)
22. 2+ signaling plasticity. In Extracellular ATP and Adenosine as the Regulators of Endothelial Cell Function, ch 11, pp. 197-213. Eds E Gerasimovskaya & E Kaczmarek. Dordrecht: Springer Publications. (doi:10.1007/978-90-481-3435-9_11)
23. 2+]i signaling vs. eNOS expression as determinants of NO output in uterine artery endothelium: relative roles in pregnancy adaptation and reversal by VEGF165. American Journal of Physiology. Heart and Circulatory Physiology 300 H1182-H1193. (doi:10.1152/ajpheart.01108.2010)
24. Zachary I 2003 VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochemical Society Transactions 31 1171-1177. (doi:10.1042/BST0311171)